Eli Lilly Files Six Lawsuits Against Companies for Illegal Sales of Experimental Obesity Drug Retatrutide
Eli Lilly has initiated six lawsuits against various U.S. companies for allegedly selling unauthorized versions of its experimental obesity drug, retatrutide, which is still undergoing clinical trials. This move highlights the company's efforts to combat the illegal market for unapproved drugs and protect consumer safety.